Cargando…
MON-559 Inappropriate Dosing of I-131 in Non-Metastatic Differentiated Thyroid Cancer
Differentiated thyroid cancer (DTC) accounts for the majority of thyroid cancers. While radioactive iodine (RAI) treatment after thyroidectomy plays an adjunctive role in some patients, the majority of patients with DTC at our institution receive RAI. The dosing of RAI is mostly empiric. A low dose...
Autores principales: | Alzenaidi, Ahlam, Ellard, Karolina, de Silva, Taniya, Hsia, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550870/ http://dx.doi.org/10.1210/js.2019-MON-559 |
Ejemplares similares
-
PSAT293 Uncommon Presentation of Hashimoto Thyroiditis
por: Alzenaidi, Ahlam
Publicado: (2022) -
MON-LB83 The Initial Dose of (131)I as a Potential Independent Predictor for Residual/Relapsed Disease in Pediatric Differentiated Thyroid Cancer
por: Bustamante Escobar, Carmen L, et al.
Publicado: (2020) -
MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020) -
MON-437 False Positive I-131 Uptake
por: Yadav, Pavan Rajendra, et al.
Publicado: (2020) -
MON-452 Poorly Differentiated Thyroid Carcinoma Metastatic to the Adrenal Gland
por: Mathias, Priyanka, et al.
Publicado: (2020)